Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty.

[1]  J. O’Keefe,et al.  Primary coronary angioplasty for acute myocardial infarction (the Primary Angioplasty Registry). , 1994, The American journal of cardiology.

[2]  C. Werter,et al.  Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis. , 1993, Journal of the American College of Cardiology.

[3]  E. Ribeiro,et al.  Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. , 1993, Journal of the American College of Cardiology.

[4]  J. Reiber,et al.  A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. , 1993, The New England journal of medicine.

[5]  J O'Keefe,et al.  A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .

[6]  K. Bailey,et al.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. , 1993, The New England journal of medicine.

[7]  K. Earle,et al.  Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. , 1992, The New England journal of medicine.

[8]  H. Hellstrom.  Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. , 1991, Circulation.

[9]  A. DeMaria,et al.  A Prospective, Randomized Trial Comparing Combination Half‐Dose Tissue‐Type Plasminogen Activator and Streptokinase With Full-Dose Tissue‐Type Plasminogen Activator , 1991, Circulation.

[10]  R. Califf,et al.  Evaluation of Combination Thrombolytic Therapy and Timing of Cardiac Catheterization in Acute Myocardial Infarction: Results of Thrombolysis and Angioplasty in Myocardial Infarction–Phase5 Randomized Trial , 1991, Circulation.

[11]  R. Califf,et al.  Identification of Acute Myocardial Infarction Patients Suitable for Early Hospital Discharge After Aggressive Interventional Therapy: Results From the Thrombolysis and Angioplasty in Acute Myocardial Infarction Registry , 1991, Circulation.

[12]  R. Califf,et al.  Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. , 1990, Circulation.

[13]  J. Gore,et al.  Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. , 1990, Circulation.

[14]  J. O’Keefe,et al.  Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. , 1989, The American journal of cardiology.

[15]  K. Lee,et al.  Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator. , 1989, Circulation.

[16]  C. White.  Recurrent ischemic events after successful thrombolysis in acute myocardial infarction. The Achilles' heel of thrombolytic therapy. , 1989, Circulation.

[17]  A. M. Skene,et al.  TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.

[18]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[19]  E. Topol,et al.  A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. , 1988, The New England journal of medicine.

[20]  K. Lee,et al.  A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. , 1987, The New England journal of medicine.

[21]  D. Rothbaum,et al.  Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience. , 1987, Journal of the American College of Cardiology.

[22]  K. Wegscheider,et al.  Risk of death from recurrent ischemic events after intravenous streptokinase in acute myocardial infarction: results from the Intravenous Streptokinase in Myocardial Infarction (ISAM) Study. , 1987, Circulation.

[23]  K. Kent,et al.  Assessment of residual coronary arterial stenosis after thrombolytic therapy during acute myocardial infarction. , 1987, The American journal of cardiology.

[24]  Y. Ohtsuki,et al.  ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.

[25]  P. Serruys,et al.  Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. , 1986, Journal of the American College of Cardiology.

[26]  B. Pitt,et al.  A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. , 1986, The New England journal of medicine.

[27]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[28]  T. Waterston.  FLUIDS FOR DIARRHŒA IN YOUNG CHILDREN , 1977, The Lancet.

[29]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .

[30]  Barr Jb,et al.  HOME OR AWAY? , 1964, Lancet.

[31]  U. Tebbe,et al.  A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): long-term mortality and morbidity. , 1987, Journal of the American College of Cardiology.

[32]  J. Spann,et al.  Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction. , 1986, The American journal of cardiology.

[33]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.